Sign in Subscribe
Mining industry

Proactive Highlights Growth Companies with Promising Developments

Strategic Insights

— 1 min read

Globex Mining Enterprises Inc, Alpine 4 Holdings, and RedHill Biopharma are among the growth companies highlighted by Proactive for their significant developments and potential. Proactive, a provider of real-time news and video interviews, has been covering these companies in various sectors, including mining, biopharma, and technology. The company's coverage has reached over 12 million views per month, and its platform delivers news to a network of over 10 million engaged investors looking for opportunities.

Key Takeaways:

  • Alpine 4 Holdings Inc expects 2Q sales to climb 54% and top $14 million, marking a significant increase from previous quarters.
  • RedHill Biopharma has completed the treatment and follow-up phase in its 475-patient global Phase 2/3 COVID-19 study with opaga, a promising COVID-19 treatment.
  • FPX Nickel Corp has appointed industry veteran Randy MacGillivray as its manager of environment and government affairs, bringing expertise to the company's environmental and government relations.
  • The Parent Company has launched an upgraded cannabis shopping app on Apple's App Store, providing customers with a modern and seamless shopping experience.
  • Logiq Inc has promoted Steven Hartman to chief operating officer, indicating the company's commitment to leadership development and growth.
  • Thor Explorations Ltd expects its first gold pour from the Segilola mine before the end of July, showcasing the company's progress in gold production.
  • CytoDyn Inc has reported strong preliminary results from 30 metastatic triple-negative breast cancer patients treated with leronlimab, a promising cancer treatment.
  • Gloex Mining Enterprises Inc has optioned the former Eagle gold mine in Quebec to Maple Gold Mines, marking a significant development in the mining sector.

Statistics:

  • Over 12 million views per month on Proactive's platforms, delivering important news to a network of engaged investors.
  • The company's coverage network reaches over 10 million private, professional, and institutional investors looking for opportunities.
  • Alpine 4 Holdings Inc expects 2Q sales to top $14 million, a 54% increase from previous quarters.
  • RedHill Biopharma has completed the treatment and follow-up phase in its 475-patient global Phase 2/3 COVID-19 study with opaga.

Sources:

  • https://www.proactiveinvestors.com/
  • https://www.globenewsire.com/
  • https://www.getprwire.com/
  • https://www.prweb.com/

Read more